Evidence map›Paper›PMID 42267786›Full record

ArticleProceedings (Baylor University. Medical Center)2026

Evaluating the quality of artificial intelligence responses to psoriasis-related clinical and patient questions: a comparative study of ChatGPT, Gemini, and Microsoft Copilot.

Gozde Ulutaş Demirbas, Esin Diremsizoglu, Abdullah Demirbas

Abstract readComparative Study
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gozde Ulutaş DemirbasDepartment of Dermatology, Kocaeli City Hospital, Kocaeli, Turkey.ORCID 0000-0002-1468-4605
Esin DiremsizogluDepartment of Dermatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.ORCID 0000-0001-9824-481X
Abdullah DemirbasDepartment of Dermatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey.ORCID 0000-0002-3419-9084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient use of artificial intelligence (AI) chatbots for dermatologic information is increasing, but their performance on psoriasis-related questions across clinically distinct domains remains unclear. We compared ChatGPT (GPT-5.3 Instant), Gemini (Gemini 3 Flash), and Microsoft Copilot using a multidimensional scoring framework.

methodsFifty-four psoriasis-related questions were submitted to each model across diagnostic (n = 12), treatment (n = 12), and patient-question (n = 30) categories. Three board-certified dermatologists independently scored responses for accuracy, evidence consistency, completeness, and clinical safety (maximum score, 8).

resultsInterrater agreement was substantial to almost perfect (κ = 0.743 for ChatGPT, 0.830 for Gemini, and 0.844 for Copilot). Overall mean scores differed significantly: 7.36 ± 0.97, 7.77 ± 0.77, and 7.05 ± 1.09, respectively (Friedman

conclusionsAll models showed high clinical safety, but Gemini provided the most complete and highest-quality responses. The observation that models may provide accurate yet clinically incomplete responses, particularly for treatment content, emphasizes the need for physician oversight when AI-generated information is used in dermatological practice.

Indexed as

Artificial IntelligencePsoriasisFemaleGenerative Artificial IntelligenceHumansSurveys and QuestionnairesArtificial intelligenceChatGPTclinical decision supportdermatologyGeminilarge language modelsMicrosoft Copilotpatient educationpsoriasis

Identifiers

PMID42267786
PMCPMC13523945

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.